AROMANDO ANDREW (Chief Operating Officer) received a stock award from AMBRX BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/11/2023ACC: 0000950170-23-069448
Officer· Chief Operating Officer
Since Dec 2023
+100K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
—
Trade value
—
% of position
1079.6%
12/11/2023
9.26K→109.26K
Total
Net shares
+100K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/11/2023 | A · Award | +100K | — | — | 1079.6% | 9.26K | 109.26K |
| Total | +100K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported